William Blair stays Outperform on Beam Therapeutics Inc (BEAM) after "decisive validation' of BEAM-302 profile

March 25, 2026 12:57 PM

William Blair analyst Sami Corwin reiterated an Outperform rating on Beam Therapeutics Inc (NASDAQ: BEAM)The analyst commented, "We view today’s ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found